These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11963196)

  • 1. [Comment on O. Hoch et al.: "Thalidomide in treatment of cutaneous and systemic sarcoidosis"].
    Ochsendorf F; Kaufmann R
    Hautarzt; 2002 Feb; 53(2):150; author reply 150-1. PubMed ID: 11963196
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cutaneous sarcoidosis with thalidomide.
    Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
    J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous sarcoidosis successfully treated with low doses of thalidomide.
    Rousseau L; Beylot-Barry M; Doutre MS; Beylot C
    Arch Dermatol; 1998 Aug; 134(8):1045-6. PubMed ID: 9722748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thalidomide in the treatment of cutaneous and systemic sarcoidosis].
    Hoch O; Müller S; Büttner G; Mensing H
    Hautarzt; 2001 Oct; 52(10 Pt 2):962-5. PubMed ID: 11715394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of thalidomide treatment during cutaneous sarcoidosis].
    Grasland A; Pouchot J; Chaumaizière D; Aitken G; Vinceneux P
    Rev Med Interne; 1998 Mar; 19(3):208-9. PubMed ID: 9775145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous sarcoidosis. Treatment with thalidomide].
    Barriere H
    Presse Med; 1983 Apr; 12(15):963. PubMed ID: 6221259
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
    Droitcourt C; Rybojad M; Porcher R; Juillard C; Cosnes A; Joly P; Lacour JP; D'Incan M; Dupin N; Sassolas B; Misery L; Chevrant-Breton J; Lebrun-Vignes B; Desseaux K; Valeyre D; Revuz J; Tazi A; Chosidow O; Dupuy A
    Chest; 2014 Oct; 146(4):1046-1054. PubMed ID: 24945194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
    Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
    Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide for chronic sarcoidosis.
    Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE
    Chest; 2002 Jul; 122(1):227-32. PubMed ID: 12114363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.
    Carlesimo M; Giustini S; Rossi A; Bonaccorsi P; Calvieri S
    J Am Acad Dermatol; 1995 May; 32(5 Pt 2):866-9. PubMed ID: 7722046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis.
    Baughman RP; Judson MA; Ingledue R; Craft NL; Lower EE
    Arch Dermatol; 2012 Feb; 148(2):262-4. PubMed ID: 22004880
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide in leprosy and some dermatological conditions--a review.
    Parikh DA; Maniar JK; Ganapati R
    Indian J Lepr; 1985; 57(4):862-7. PubMed ID: 3915010
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sarcoidosis: thalidomide treatment in ten patients].
    Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A
    Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report.
    Lee JB; Koblenzer PS
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):835-8. PubMed ID: 9810910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.
    Oliver SJ; Kikuchi T; Krueger JG; Kaplan G
    Clin Immunol; 2002 Mar; 102(3):225-36. PubMed ID: 11890709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide: dermatological indications, mechanisms of action and side-effects.
    Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
    Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of muscle sarcoidosis with thalidomide.
    Walter MC; Lochmüller H; Schlotter-Weigel B; Meindl T; Müller-Felber W
    Acta Myol; 2003 May; 22(1):22-5. PubMed ID: 12966701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide and its dermatologic uses.
    Moraes M; Russo G
    Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based therapy for cutaneous sarcoidosis.
    Baughman RP; Lower EE
    Clin Dermatol; 2007; 25(3):334-40. PubMed ID: 17560311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α: a treatment target or cause of sarcoidosis?
    Amber KT; Bloom R; Mrowietz U; Hertl M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2104-11. PubMed ID: 26419478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.